SingleCare

SingleCare is a free prescription discount service that negotiates directly with pharmacies to offer savings of up to 80% on more than 10,000 brand-name and generic medications. Available at 35,000+ pharmacies nationwide, it requires no membership fees, insurance, or subscriptions. By late 2022, more than 40 million Americans had used SingleCare, and it was adding about 7 million new users a year.

24/ 100
Early Warning
1No Decay→Stable

Score generated by AI agents based on publicly cited evidence and reviewed by the project maintainer. Not independently validated. Last assessed 2026-10-26.

Score History

MilestoneCriticalMajor
RxSense Launch (2015–2018) · 13/100RxSense LaunchFamilyWize Acquisition (2018–2020) · 15/100FamilyWizeAcquisiti…PE Growth Ramp (2020–2023) · 21/100PE Growth RampDrugmaker Ads & Scrutiny (2023–present) · 24/100Drugmaker Ads & Scrutiny10075502502016202020242026-10RxSense Launch (2015–2018) · 13/100FamilyWize Acquisition (2018–2020) · 15/100PE Growth Ramp (2020–2023) · 21/100Drugmaker Ads & Scrutiny (2023–present) · 24/10013152124MilestonesFounded (2015)Acquired FamilyWize (2018)Parthenon Capital Investment (2020)Acquired Paramount Rx (2022)Events

Timeline events are AI-curated from public reporting. Score trajectory is derived from documented events.

RxSense Launch
13/100
2015-01-01 – 2018-12-01

Rick Bates founds RxSense in Boston and launches SingleCare, a free discount card priced through direct pharmacy contracts, with an iOS app in May 2015. The product is free, needs no account and has no lock-in; pricing is negotiated privately, as in any discount card. The one blemish surfaced later, when a class action alleged SingleCare had sent unsolicited advertising faxes during these years.

FamilyWize Acquisition
15/100+2
2018-12-01 – 2020-05-12

RxSense buys FamilyWize, a discount card distributed through United Way and other nonprofits, gaining distribution rather than removing a direct rival. In March 2019 SingleCare settles the junk-fax class action ($925,110 fund) without admitting wrongdoing. In December 2019 it launches its first national TV campaign, with Martin Sheen, followed by a WebMD partnership in January 2020.

PE Growth Ramp
21/100+6
2020-05-12 – 2023-07-13

Parthenon Capital's growth recapitalization, financed partly by an Antares senior secured credit facility, puts private equity on the RxSense board. SingleCare scales to the mass market through celebrity campaigns, a Member Savings loyalty program that requires an account (July 2020), the FamilyWize brand merger (2021) and the Paramount Rx acquisition (2022). It publicly explains why prices can change between fills (2020), while journalists document health apps sharing data with advertisers outside HIPAA (2022).

Drugmaker Ads & Scrutiny
24/100+3
2023-07-13 – present

SingleCare launches Pharma Solutions, which lets drugmakers market copay programs to its users. It comes months after the FTC's GoodRx case put prescription-app data sharing under federal scrutiny. RxSense powers Walgreens' Rx Savings Finder marketplace (November 2023), Accountable Tech names SingleCare among coupon companies collecting and selling consumer data (2024), and BBB complaints document unsolicited activated cards and mailers resembling insurance cards (2024-2025). The core free service is intact, and the parent keeps hiring.

Alternatives

Mark Cuban's online pharmacy prices drugs at its cost plus a 15% markup, a $5 pharmacy fee and $5.25 shipping, with the price breakdown shown up front. Its catalog is mostly generics with some brand-name drugs and is smaller than SingleCare's. Easy switch for covered medications.

GoodRx46/100

Largest prescription discount service, accepted at 70,000+ pharmacies (double SingleCare's network). The free tier offers comparable savings, and its paid GoodRx Companion membership (formerly Gold; $14.99/month, or $9.99/month billed yearly) adds deeper discounts and free medications. More features, including telehealth visits. Easy switch: use both side by side and compare per prescription. Note: GoodRx agreed to a $1.5M FTC civil penalty in 2023 and a $25M class-action settlement in 2024 over sharing users' health data with advertisers.

Dimensional Breakdown

Summaries below were written by AI agents based on the cited evidence. They are editorial interpretations, not independent research findings.

User Value Erosion
SingleCare is still a free, working prescription discount service. There is no membership or fee, and its coupons are accepted at about 35,000 U.S. pharmacies, roughly half of GoodRx's 70,000+. The recurring problem is price reliability: SingleCare says listed prices are estimates that can change, and Trustpilot and BBB complaints describe counter prices that did not match the app. Reviews remain mostly positive, the company claims average annual savings of over $270, and no features have been removed or paywalled. That fits minor annoyances rather than a decline.
How It Got Here
SingleCare launched in 2015 with a simple proposition: free prescription discounts negotiated directly with pharmacies, with an iOS app from May 2015. The core product has stayed free and useful. FamilyWize, which RxSense bought in 2018, had passed $1 billion in user savings by 2016, and SingleCare now claims more than $11 billion saved. During the 2020 pandemic SingleCare shifted toward delivery to keep people supplied while sheltering in place. Price reliability has been the persistent weakness. In October 2020 SingleCare explained to users why their savings could change between fills, and Trustpilot and BBB complaints since then describe counter prices that differed from the app; SingleCare answers that listed prices are estimates. Its network of about 35,000 pharmacies is roughly half GoodRx's. On the positive side, RxSense's 2025 RXnotify tool and its 2026 RxUtility integration put SingleCare pricing in more places. Reviews remain mostly positive and no features have been removed or paywalled, so the record shows minor annoyances rather than a degraded product.
Business Customer Exploitation
Shareholder Extraction
Lock-in & Switching Costs
Twiddling & Algorithmic Opacity
Dark Patterns
Advertising & Monetization Pressure
Competitive Conduct
Labor & Governance
Regulatory & Legal Posture

Dimension History

2015RxSense Launch2018FamilyWize Acquisition2020PE Growth Ramp2023Drugmaker Ads & ScrutinyUser Value1122Biz Exploit2233Shareholder1122Lock-in0011Algorithms2223Dark Patterns1113Advertising1122Competition1233Labor/Gov2222Regulatory2333
Timeline (44 events)
major2015-01-01

Rick Bates Founds RxSense in Boston

Rick Bates, former president and COO of Catalyst Health Solutions (which later became Catamaran), founds RxSense in Boston as a healthcare technology company. The company creates SingleCare, a pharmacy savings card marketed directly to consumers.

major2015-05-25

SingleCare Mobile App Launches on iOS

SingleCare releases its mobile app on the Apple App Store, providing users with a free digital prescription discount card. The app allows users to search medication prices, compare pharmacy costs, and present digital coupons at the counter, removing the need for physical discount cards.

major2016-03-01

FamilyWize Reaches $1 Billion Savings Milestone

FamilyWize, the Bethlehem, PA-based prescription discount program begun in 2005, announces that over 9 million uninsured and underinsured people have saved more than $1 billion on their medications through its free prescription savings card and app, offered through partners including United Way.

major2018-12-01

RxSense Acquires FamilyWize Prescription Program

RxSense acquires FamilyWize, the Bethlehem-based prescription discount program that had operated since 2005 through United Way and other community partnerships. The deal gives SingleCare FamilyWize's established nonprofit distribution network, significantly expanding its reach.

major2019-03-07

SingleCare Settles Junk-Fax Class Action for $925,110

SingleCare Services agreed to settle a Florida class action (Broward Psychology PA v. SingleCare Services LLC) alleging it sent unsolicited advertising faxes, in violation of the Telephone Consumer Protection Act, to about 10,000 individuals and entities with which it had no business relationship. The settlement covered faxes sent between September 25, 2014 and January 29, 2019, with a $925,110 fund and claims of up to $95. SingleCare did not admit wrongdoing.

major2019-12-25

Martin Sheen National TV Campaign Launches

SingleCare launches its first major national television advertising campaign featuring Martin Sheen, who addresses the high cost of prescription drugs in the United States. The campaign, developed by Boathouse Agency, airs on national TV and online. Charlie Sheen also appears in the spots. This marks SingleCare's shift to aggressive consumer marketing.

major2020-01-14

SingleCare Partners with WebMD to Launch WebMDRx

SingleCare announces a partnership with WebMD to power WebMDRx, a service allowing WebMD's millions of monthly visitors to compare prescription drug prices at local pharmacies and save up to 80%. Users can search medications, find the lowest price, and text, print, or email a coupon directly from WebMD.

minor2020-01-29

RxSense Launches RxIQ Analytics Platform

RxSense announces the launch of RxIQ, a leading-edge analytics product within its RxAgile enterprise platform for pharmacy benefits administration. RxIQ provides real-time health plan performance insights through customizable dashboards with hourly data updates, allowing PBM clients to optimize operations and pricing.

minor2020-03-16

RxSense Named Fast Company #7 Most Innovative Health Company

RxSense, SingleCare's parent company, is named #7 in the Health category of Fast Company's 2020 World's Most Innovative Companies, among 434 honorees worldwide. The same day it is named to the inaugural Forbes list of America's Best Startup Employers (ranked #287).

minor2020-04-16

SingleCare Responds to COVID-19 with Delivery and Outreach

During the COVID-19 pandemic, SingleCare CEO Rick Bates tells Yahoo Finance the company has shifted its focus toward delivery services to maintain medication access for people sheltering in place.

critical2020-05-12

Parthenon Capital Invests in RxSense

RxSense announces a significant investment from Parthenon Capital, a growth-oriented private equity firm managing funds with more than $5 billion in total capital commitments. Terms are not disclosed. Jeffery Boyd (Chairman of Booking Holdings, former CEO of Priceline Group) and John Hayes join the RxSense board of directors, bringing significant consumer technology experience.

minor2020-07-09

SingleCare Launches Member Savings Loyalty Program

SingleCare introduces its Member Savings loyalty program, offering a $3 sign-up bonus and $1 earned toward next fill on nearly every prescription. The free program requires users to create an account with name, date of birth, and email, representing a shift from the no-account-required model toward collecting user data in exchange for incremental savings.

minor2020-07-09

Antares Debt Financing Backs Parthenon's RxSense Recapitalization

Antares announced it was lead left arranger and administrative agent on a senior secured credit facility supporting Parthenon Capital's growth recapitalization of RxSense, meaning the private equity deal was financed partly with debt. Terms were not disclosed.

minor2020-07-10

SingleCare Survey Finds Pandemic Pushed Americans to Skip Medications

A SingleCare online survey of 1,000 U.S. adults, fielded June 3, 2020, finds that 21% stopped taking medications since the COVID-19 pandemic began because of cost and/or access, and 27% skipped doctor's appointments due to financial constraints created by the pandemic and recession.

minor2020-10-05

SingleCare Explains Why Prescription Prices Change Between Fills

In an 'Ask SingleCare' post, the company tells users that their savings can differ at the counter even when the pharmacy, quantity and medication are unchanged, because it continually re-evaluates pricing based on market conditions and the discounts it negotiates with pharmacies. The factors behind any given price are not disclosed.

minor2020-12-03

RxSense Powers Hy-Vee's New PBM Vivid Clear Rx

RxSense partners with grocery chain Hy-Vee to launch Vivid Clear Rx, a new pharmacy benefit management subsidiary serving Hy-Vee's 88,000+ employees and other employers. Vivid Clear Rx is powered by RxSense's RxAgile enterprise technology and RxIQ analytics.

minor2021-01-01

John Leguizamo Stars in First Spanish-Language Campaign

SingleCare partners with Emmy-winning actor John Leguizamo for its first Spanish-language advertising campaign, coinciding with the launch of a Spanish-language version of the website. The campaign targets Hispanic Americans, who are nearly three times more likely to be uninsured than non-Hispanic whites.

minor2021-01-26

RxSense Partners with National Healthcare Solutions

RxSense provides its RxAgile enterprise platform to VerusRx, the newly launched PBM subsidiary of National Healthcare Solutions Inc. (NHSI). VerusRx also launches a prescription discount card powered by SingleCare, allowing members with benefit limits to access discounted out-of-pocket medications.

minor2021-03-09

RxSense Named Forbes Best Startup Employer Second Consecutive Year

RxSense is recognized on Forbes' America's Best Startup Employers 2021 list for the second consecutive year, ranking #148. Forbes and Statista selected the top 500 companies based on employee satisfaction, employer reputation, and company growth, using over 7 million data points.

major2021-04-26

FamilyWize Brand Merges Under SingleCare Name

FamilyWize, the prescription savings program that had operated through United Way and other nonprofit partnerships, combines with its sibling brand SingleCare. The combined program offers an expanded roster of discounts at 35,000 pharmacies nationwide. Grove City Area United Way tells existing cardholders their FamilyWize cards will continue to work. United Way of Pennsylvania says SingleCare will continue partnerships with over 800 local United Ways and United Way Worldwide.

major2021-12-21

Martin Short National TV Campaign Launches

SingleCare partners with Emmy and Tony award-winning actor Martin Short on a new national television advertising campaign, set to air in late December, in which Short discovers SingleCare's savings from his pharmacist at his local pharmacy.

major2022-02-01

RxSense Acquires Paramount Rx Discount Card

RxSense Group, a Parthenon Capital portfolio company, bought Paramount Rx Inc., with Piper Sandler advising the seller. Terms were not disclosed. Paramount Rx is a prescription discount card that RxSense now runs alongside SingleCare as one of its proprietary discount card brands.

minor2022-05-02

EmsanaRx Selects RxSense to Power PBM for Major Employers

EmsanaRx, a PBM created by the Purchaser Business Group on Health (PBGH, a coalition of large employers including Microsoft, Walmart and American Airlines), selects RxSense to power its pharmacy benefits technology. The partnership provides large self-insured employers with transparent, real-time pharmacy benefits management. Healthcare Dive also identified Tesla as a PBGH member when Emsana launched in October 2021.

minor2022-09-21

RxSense Named Modern Healthcare Best Places to Work

RxSense is recognized as one of the 2022 Best Places to Work in Healthcare by Modern Healthcare. The company has 277 U.S. employees at the time with 15% voluntary turnover. Employees highlight the company's employee-first culture, work/life balance, and collaborative environment. RxSense also reports investing in DEI programs including a leadership program for women.

major2022-09-22

Washington Post Exposes Health App Data Sharing with Advertisers

The Washington Post publishes an investigation finding that popular health apps, including the Drugs.com, WebMD and Period Calendar Android apps, share potential health concerns and user identifiers with dozens of advertising and analytics companies. The report highlights that HIPAA offers users few protections for health data gathered by phone apps and websites, meaning it can be used for advertising.

minor2022-12-20

Martin Short Returns for Second SingleCare Campaign

SingleCare returns with Martin Short for a second year, in a national TV and digital campaign that again features him at his local pharmacy, where 'Marty' insists he still has a story to tell about SingleCare savings. SingleCare's Shorty Awards entry for the campaign reports a 196% increase in app downloads, a 172% increase in loyalty-program enrollment and 112% growth in direct website visits since launch.

major2023-01-24

Amazon RxPass Enters Prescription Discount Market

Amazon launches RxPass, offering Prime members unlimited generic prescriptions for 50 common medications at $5/month with free delivery. The move increases competitive pressure on prescription discount services like SingleCare and GoodRx, particularly for common generics. RxPass is available in 42 states at launch.

critical2023-02-01

FTC Proposes $1.5M Penalty on GoodRx for Unauthorized Health Data Sharing

The FTC takes its first enforcement action under the Health Breach Notification Rule against GoodRx for sharing users' prescription medications, health conditions, and personal information with Facebook, Google, Criteo, and other third parties for advertising. Under a proposed federal court order, GoodRx would pay a $1.5 million civil penalty and be permanently prohibited from sharing user health data with advertising third parties. The action sets a precedent for all prescription discount services. The complaint alleges that GoodRx shared users' personal and health information with advertising platforms and other third parties beginning in 2017.

minor2023-04-06

Former Executive's Suit Against SingleCare and RxSense Allowed to Proceed

The North Carolina Supreme Court held that state courts may exercise personal jurisdiction over SingleCare Holdings, SingleCare Services and RxSense Holdings in a suit by David Schaeffer, their former Senior Vice President of Business Development, over alleged breach of his employment agreements. It remanded the case and affirmed dismissal of claims against CEO Rick Bates and another executive. The ruling addressed jurisdiction only, not the merits.

major2023-05-18

FTC Proposes Expanding Health Breach Notification Rule

The FTC proposes amendments to strengthen and modernize the Health Breach Notification Rule, clarifying that health apps and similar technologies not covered by HIPAA are covered, following its GoodRx and Premom cases. The proposed changes expand what constitutes a breach of security to include unauthorized disclosures, which bears on prescription discount services like SingleCare that share data with advertising partners. The proposal specifically identifies GoodRx, a provider of prescription medication discounts, among the vendors of personal health records against which the FTC had enforced the rule.

major2023-07-13

SingleCare Launches Pharma Solutions for Drug Manufacturers

SingleCare launches its Pharma Solutions product, enabling pharmaceutical companies to market copay assistance programs directly to SingleCare's seven million monthly users. The offering gives drug manufacturers access to advertise directly to high-intent, bottom-of-funnel prescription customers, creating a new revenue stream that raises questions about whether displayed prices optimize for consumer savings or manufacturer relationships.

minor2023-07-13

SingleCare Says It Was the Fastest-Growing Prescription Discount Card of 2022

In a July 2023 Drug Channels guest post, SingleCare's head of Pharma Solutions says SingleCare was the fastest-growing prescription discount card of 2022 and holds the #2 market position in the space. The company handles hundreds of thousands of prescriptions per day through direct partnerships with CVS, Walgreens, Walmart, Kroger, Albertsons, Hy-Vee, Publix, and Meijer.

minor2023-11-30

RxSense Powers Walgreens' Rx Savings Finder Marketplace

RxSense launched Rx Savings Finder with Walgreens, a free website where customers compare prices from a variety of prescription discount cards and pick a coupon to use at Walgreens pharmacies nationwide. RxSense, which owns the SingleCare card, operates the marketplace; the announcement does not say how cards are ranked.

minor2024-03-20

RxSense Named to Forbes and USA Today Best Workplaces Lists

RxSense is named to Forbes' list of America's Best Startup Employers for the third time and receives USA Today's 2024 Top Workplaces USA award, one of 1,500 companies honored based on Energage employee engagement surveys.

major2024-03-31

Washington My Health My Data Act Takes Effect

Washington state's My Health My Data Act, signed by Governor Inslee on April 27, 2023, takes effect on March 31, 2024 for most regulated entities (June 30, 2024 for small businesses). The first state law aimed at gaps in protection for consumer health data outside HIPAA, it reaches entities that collect such data from Washington consumers, a scope that can include health and prescription apps, requiring separate opt-in consent to collect or share health data, banning geofencing around health facilities, and giving consumers a private right of action.

critical2024-06-10

Accountable Tech Exposes Prescription Coupon Data Practices

Accountable Tech publishes an analysis of three prescription coupon companies, GoodRx, WellRx and SingleCare, concluding that they are 'blatantly collecting and selling consumers' personal information.' The report notes these apps fall outside HIPAA, and that GoodRx, for example, collects purchase history, insurance information and personal identifiers and shares data with third parties for targeted advertising. The analysis references the FTC's GoodRx enforcement action; in that case, the FTC alleged that GoodRx shared sensitive health information contrary to its privacy promises.

critical2024-07-29

FTC Finalizes Expanded Health Breach Notification Rule

The FTC's updated Health Breach Notification Rule takes effect, applying the rule to health apps, connected devices and other online services not covered by HIPAA. The rule expands breach definitions to include unauthorized disclosures and requires notification to consumers identifying which third parties received their data, which bears on SingleCare's data-sharing with advertising networks. Its enforcement-history discussion specifically identifies GoodRx, which offers prescription medication discounts, as a vendor of personal health records subject to enforcement under the rule.

minor2024-08-01

Consumers Report Unsolicited Activated Discount Cards

BBB complaints document consumers receiving already-activated SingleCare prescription discount cards they never requested, with personal information used without consent. Some consumers request their accounts be closed and information removed from all mailing lists. SingleCare states removal from mailing lists takes 'a maximum of 60 days.'

minor2025-01-01

Price Discrepancy Complaints at Pharmacy Counters

Some SingleCare reviews on Trustpilot complain that the price rung up at the pharmacy did not match the coupon price shown on SingleCare's site or app, sometimes by large amounts. SingleCare's replies point to its fine print that listed prices are estimates. Related BBB complaints concern RxSense's Rx Savings Finder app.

major2025-05-20

BBB Complaints Document Misleading Direct Mailers

Consumer complaints filed with the Better Business Bureau describe SingleCare sending mailers with envelopes stating 'New 2025 cards inside,' which recipients mistake for health insurance cards. Consumers describe the tactic as 'borderline gross' and 'unreasonable for a business to pretend to be a health insurance company as a form of clickbait.' SingleCare acknowledges the 'envelope message may have led to a misunderstanding' but notes the card itself states it is not insurance.

minor2025-07-08

RxSense Partners with RXNT to Launch RxNotify

RXNT and RxSense launch RXnotify, a secure text-based prescription tool that sends patients timely prescription updates and pharmacy discount alerts. RxSense's savings network covers nearly 50,000 pharmacies, and the tool aims to improve medication adherence and reduce prescription abandonment.

minor2025-12-10

RxSense Announces Dublin Office and 75 Tech Jobs

RxSense announced it will open its first European office, in Dublin, creating 75 full-time engineering and product jobs. The company said the centre will help build its next generation of products, including AI work.

minor2026-05-11

RxSense Named a Modern Healthcare Best Place to Work for Fifth Time

RxSense announced it had been named one of Modern Healthcare's Best Places to Work for the fifth time. The program is based on employee surveys of engagement, culture, leadership and satisfaction, run with the Workforce Research Group.

minor2026-05-20

RxSense Brings SingleCare Pricing to RxUtility

RxUtility and RxSense announced a partnership under which RxUtility's medication-affordability platform will add pricing and pharmacy networks from RxSense's discount card brands, including SingleCare and Paramount Rx, through a single API, so users can compare savings options in one workflow.

Evidence (51 citations)
Scoring Log (7 entries)
regrade2026-10-26RESCORED

24→24. Since Oct 2025: RxSense announced a Dublin office with 75 jobs (Dec 2025), a fifth Modern Healthcare Best Places to Work award (May 2026) and an RxUtility pricing integration including SingleCare (May 2026), and SingleCare published a pharmacist guide conceding some below-cost claims (Sep 2026); no enforcement, lawsuits, fee changes or breaches found. D1 3→2 (recalibration: free core service intact, price-estimate mismatches are minor annoyances, no feature loss or paywalling, so 2-3 band lower end). D8 2→3 (event: historical gap Paramount Rx discount-card acquisition Feb 2022, second brand buy after FamilyWize, plus RxSense-run comparison marketplaces). Eras: 'RxSense Launch' and 'FamilyWize Acquisition' kept and re-scored; 'PE Growth Ramp' re-dated 2020-05-01→2020-05-12 (Parthenon announcement); final era re-dated 2026-02-19 (scoring date)→2023-07-13 (Pharma Solutions launch) and relabeled 'Data Scrutiny Era'→'Drugmaker Ads & Scrutiny'. Historical gaps filled: 2019 TCPA junk-fax settlement (closes uncovered D10 2018-2020 cell), 2020 Antares debt financing of the Parthenon recap, 2020 price-change disclosure, 2022 Paramount Rx acquisition (+milestone), 2023 Schaeffer jurisdiction ruling, 2023 Walgreens Rx Savings Finder. Pharma Solutions event redated 2023-07-01→2023-07-13 per Drug Channels post date. Skipped: GoodRx $32M settlement preliminary approval and court-entered FTC order (competitor matters), FTC 2026 rescission of 2021 health-app policy statement (no SingleCare bearing), TailorMed integration (does not name SingleCare). Glassdoor reviews alleging RxSense layoffs (handoff lead 5) could not be opened (HTTP 403) and no news report of layoffs was found, so none are claimed. d9 narrative no longer repeats the Inc. 2023 Best Workplaces claim, which was not re-verified.

restore-check2026-10-26RESTORED

Checked 13 removed/trimmed candidates: 0 restored, 6 partly restored, 6 confirmed removed, 1 already present. PARTLY RESTORED: FamilyWize card validity and continued United Way partnerships (Grove City Area United Way; United Way of Pennsylvania); Tesla PBGH membership (Healthcare Dive); alleged sharing since 2017 (FTC complaint); prescription-discount coverage narrowed to GoodRx in the 2023 NPRM and 2024 final rule (FTC); sharing contrary to privacy promises narrowed to the FTC's allegation against GoodRx (FTC, linked from Accountable Tech). Added evidence entries document these sources and verdicts. ALREADY PRESENT: 'behind GoodRx' is in the regraded D8 summary; unsupported June 2022 dating and 'surpassing competitors' remain out. CONFIRMED REMOVED under the guide's evidence standard: Catalyst $2.5B-to-$5.7B growth (found only a self-promotional Forbes Council bio; direct pharmacy contracting is already present in prose); Washington Post investigation's supposed prescription-discount-app inclusion (read archived article, which names other apps); 2024 Inc./MedTech awards (Inc. page unreadable after retries/Wayback; official MedTech text did not identify RxSense; company marketing alone excluded); exact BBB price cases (search leads point to individual reviews, not qualifying independent evidence; complaints page read does not show those figures); RXnotify personalized links (patient marketing page says this, but no qualifying independent source found); Hot-Med comparison (unreadable live/archive and three searches found no qualifying original). No failed fetch is treated as proof a claim is false. No score or existing item removed.

fact-audit2026-10-25FABRICATION FOUND

Checked 76 items (34 timeline, 37 evidence, 3 milestones, 2 alternatives) + prose. 14 verified, 37 corrected (20 date-only), 23 re-sourced, 2 removed (1 junk source, 1 wrong entity). Invented (contradicted): 'GoodRx fined $25M by the FTC' in d10 summary and the GoodRx alternative (FTC release: $1.5M civil penalty; $25M was a separate class settlement); 'SingleCare distributes discount cards to HR departments' (SingleCare's 2021 blog shows a United Way staffer did this). 18 unsupported details trimmed, incl. Catalyst '$2.5B to $5.7B', Generation Partners, $885M PitchBook funding, 2024 restructuring, MedTech/Inc. 2024 awards, $35/$200+ and $210/$450 price cases, PBGH Disney/Salesforce. Member Savings redated 2023 to 2020; MHMDA redated to 2024-03-31; added 2020 survey event.

deep-enrichment-reset2026-03-20

Stripped for Phase 2 re-enrichment

Deep Enrichment2026-03-20
Alternatives Review2026-02-21GOOD
Initial Scoring2026-02-19